High Tower Advisors, LLC Alpha Tau Medical Ltd. Transaction History
High Tower Advisors, LLC
- $68.3 Billion
- Q3 2024
A detailed history of High Tower Advisors, LLC transactions in Alpha Tau Medical Ltd. stock. As of the latest transaction made, High Tower Advisors, LLC holds 230,704 shares of DRTS stock, worth $514,469. This represents 0.0% of its overall portfolio holdings.
Number of Shares
230,704
Previous 230,704
-0.0%
Holding current value
$514,469
Previous $583,000
5.83%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding DRTS
# of Institutions
29Shares Held
1.36MCall Options Held
0Put Options Held
0-
Levin Capital Strategies, L.P. New York, NY307KShares$685,3340.07% of portfolio
-
Hoyle Cohen, LLC269KShares$600,0660.05% of portfolio
-
ETF Managers Group, LLC Summit, NJ66.3KShares$147,9060.01% of portfolio
-
Satovsky Asset Management LLC53.6KShares$119,5410.03% of portfolio
-
Private Advisor Group, LLC47.6KShares$106,1100.0% of portfolio
About Alpha Tau Medical Ltd.
- Ticker DRTS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,011,296
- Market Cap $154M
- Description
- Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast canc...